Skip to main content

House Bill

H.R. 7407

119th Congress

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

In Committee
Introduced:Feb 5, 2026

Primary Sponsor

Sponsor information unavailable

Cosponsors

0

Quick Stats

Summary

This bill would prohibit tianeptine and other products deemed dangerous. Tianeptine is a substance that has been sold as a dietary supplement or research chemical, though it acts similarly to opioids and has raised safety concerns.

Latest Action

Referred to the House Committee on Energy and Commerce.

Introduced2/5/2026
StatusReferred to the House Committee on Energy and Commerce.
ChamberHouse
Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

This bill would prohibit tianeptine and other products deemed dangerous. Tianeptine is a substance that has been sold as a dietary supplement or research chemical, though it acts similarly to opioids and has raised safety concerns.

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would prohibit tianeptine and other products deemed dangerous. Tianeptine is a substance that has been sold as a dietary supplement or research chemical, though it acts similarly to opioids and has raised safety concerns.

Bill Number
7407
Introduced
2/5/2026
Status
Referred to the House Committee on Energy and Commerce.

Data from Congress.gov

AI-generated summary

Fact Sheet

Title
Prohibiting Tianeptine and Other Dangerous Products Act of 2026
Bill Number
7407
Sponsor
No sponsor
Status
Referred to the House Committee on Energy and Commerce.
Introduced
2/5/2026
Summary
This bill would prohibit tianeptine and other products deemed dangerous. Tianeptine is a substance that has been sold as a dietary supplement or research chemical, though it acts similarly to opioids and has raised safety concerns.

Data from Congress.gov

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.